Department of Hand and Plastic Surgery, Linköping University Hospital, Linköping, Sweden.
J Vasc Surg. 2011 Feb;53(2):435-44. doi: 10.1016/j.jvs.2010.08.019. Epub 2010 Oct 27.
Dense angiogenic sprouting occurs from arteriovenous loops (AVLs) incorporating autologous vein grafts inserted into empty plastic chambers in vivo. The purpose of this study was to determine if angiogenesis from the AVL was limited by substituting an "off the shelf" cold-stored allograft vein instead of an autologous vein.
Four Sprague Dawley rat groups (two AVL configurations × two chamber types) were established for both 2-week and 6-week harvest. Control AVLs were autologous femoral vein grafts harvested from the left femoral vein that were surgically inserted between the cut femoral artery and vein on the right side. Experimental "allograft" AVLs were rat femoral veins cold-stored (4°C, sterile) for 4 to 7 weeks and then microsurgically interposed between the right femoral artery and vein of an unrelated rat. The two AVL types were inserted in one of two plastic chamber types--smooth or perforated. At harvest, the AVL constructs were checked for patency, weighed, their volume determined, and histology undertaken. Morphometric assessment of percent and absolute volume of major tissue components (including blood vessels) at 6 weeks was completed.
There were no significant differences between autograft and allograft groups in construct weight, volume, or morphology at 2 or 6 weeks. No statistical differences occurred in the percent or absolute vascular volume of AVLs incorporating a cold-stored allograft vs autologous vein grafts at 6 weeks regardless of the chamber type. However, perforated chambers caused significant increases in construct weight (P = .015), volume (P = .006), and percent and absolute connective tissue volume at 6 weeks (P = .001) compared to smooth chamber constructs, regardless of the graft type.
Cold-stored small-caliber allografts interposed in AVLs do not inhibit microcirculatory development and can be used in composite tissue engineering.
在体内,含有自体静脉移植物的动静脉环(AVL)从空塑料室内发生密集的血管生成发芽。本研究的目的是确定是否可以通过替代“现成的”冷藏同种异体静脉来限制从 AVL 发生的血管生成,而不是使用自体静脉。
建立了四个斯普拉格-道利大鼠组(两个 AVL 构型×两种室类型),用于 2 周和 6 周收获。对照 AVL 是从左侧股静脉采集的自体股静脉移植物,通过手术插入右侧股动脉和股静脉之间。实验“同种异体移植物”AVL 是在 4°C (无菌)下冷藏 4 至 7 周的大鼠股静脉,然后通过显微外科技术插入无关大鼠的右侧股动脉和股静脉之间。两种 AVL 类型插入两种塑料室类型之一——光滑或穿孔。收获时,检查 AVL 结构的通畅性、称重、确定其体积,并进行组织学检查。在 6 周时完成对主要组织成分(包括血管)的百分比和绝对体积的形态计量评估。
在 2 周和 6 周时,自体移植物和同种异体移植物组在结构重量、体积或形态方面没有显著差异。无论腔室类型如何,在 6 周时,纳入冷藏同种异体移植物与自体静脉移植物的 AVL 的血管百分比或绝对体积均无统计学差异。然而,与光滑腔室结构相比,穿孔腔室在 6 周时导致结构重量(P =.015)、体积(P =.006)以及百分比和绝对结缔组织体积显著增加(P =.001),而与移植物类型无关。
插入 AVL 中的冷藏小口径同种异体移植物不会抑制微循环发育,可用于复合组织工程。